Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of new CEO

6 Dec 2021 07:00

RNS Number : 6050U
Cellular Goods PLC
06 December 2021
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Press Release

6 December 2021

 

Cellular Goods PLC

("Cellular Goods" or "The Company") 

 

Appointment of new Chief Executive Officer

 

 

The Board of Cellular Goods plc is pleased to announce the appointment of Anna Chokina as Chief Executive Officer and Director to drive the Company's next stage of growth following the launch of its inaugural product range on 1 December 2021.

 

Anna succeeds Alexis Abraham, who becomes Chief Strategy Officer, and both appointments take effect from 6 December 2021.

 

Anna is a highly successful and experienced executive having spent more than 20 years in senior level roles in the fast-moving consumer goods industry. She was previously the Vice President of Global Colour Cosmetics, Global Face Care and Personal Care at Avon where she established a solid track record of implementing business transformation in a competitive environment. Moreover, during her tenure at Avon, Anna successfully launched Avon's first-ever lines of cannabidiol (CBD) based products for the personal care and skincare market. Prior to that Anna was General Manager of L'Oreal Paris for Russia, delivering three consecutive years of growth despite an economic recession.

 

Her other previous senior roles included leading the $800 million snacks portfolio for PepsiCo Russia and, prior to that, a decade managing large portfolios for Procter & Gamble including feminine hygiene, healthcare and pet care in both the US and the UK.

 

Alexis, who has served as Chief Executive Officer since February 2021, successfully led the Company through its first stage of development, its flotation on the London Stock Exchange and the launch of its first range of skincare and ingestibles in less than a year. In his new role Alexis will be focussing on brand positioning and product development. He remains a Director on the Board.

Peter Wall, Chairman of Cellular Goods, said: "On behalf of the Board, I would like to thank Alexis for his hard work and ongoing commitment to Cellular Goods. Under his leadership the Company has established a strong foundation as the first pure-play consumer cannabinoid brand to list on the LSE and successfully launched its inaugural product ranges just nine months after the start-up of commercial operations.

"Anna's appointment heralds an exciting new chapter for Cellular as the Company enters its revenue generating phase and her deep expertise will help guide the future direction of the Company. She has a proven track record with several global consumer brands and is the right leader to drive Cellular to the next level. Our ambition for the Company is significant and clear and the entire Company and the Board look forward to working with her."

Anna Chokina, Chief Executive of Cellular Goods, commented: "I am excited to join Cellular Goods at this point of development, following the launch of its inaugural product range. I am proud to be joining a company that produces high-quality, research-backed products and that champions the use of innovative and sustainable lab-made cannabinoids. I believe there is a significant opportunity to harness the strengths of the business to successfully deliver the planned product expansion and brand elevation. I am looking forward to working with the whole Cellular team to build a strong business for our customers, our employees, our partners and to deliver long-term value for our shareholders."

Alexis Abraham, Chief Strategy Officer of Cellular Goods, said: "I am immensely proud to have been able to realise our growth strategy in a far shorter time period than anticipated and am delighted to pass the baton to Mrs Chokina. Last week we launched our inaugural products and Cellular Goods is ideally positioned to become the leading player in the space".

For further information please contact:

Cellular Goods

Anna Chokina

Chief Executive

Neil Thapar

Investor Relations

via Tancredi +44 207 887 7633

 

+44 787 645 5323

Tennyson Securities

Corporate Broker

Peter Krens

 

+44 207 186 9030

Novum Securities

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427 

Tancredi Intelligent Communication

Media Relations

Helen Humphrey

Edward Daly

Charlie Hobbs

cellulargoods@tancredigroup.com

 

+44 744 922 6720

+44 786 143 0057

+44 789 755 7112

 

 

About Cellular Goods PLC

 

Cellular Goods is a U.K.-based provider of premium consumer products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid products. The initial focus is on three product verticals: premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website.

 

www.cellulargoods.co 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATFBMTMTMMMAB
Date   Source Headline
9th Mar 202111:05 amRNSSecond Price Monitoring Extn
9th Mar 202111:00 amRNSPrice Monitoring Extension
2nd Mar 20212:06 pmRNSSecond Price Monitoring Extn
2nd Mar 20212:00 pmRNSPrice Monitoring Extension
2nd Mar 20219:05 amRNSSecond Price Monitoring Extn
2nd Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
1st Mar 20219:05 amRNSSecond Price Monitoring Extn
1st Mar 20219:00 amRNSPrice Monitoring Extension
26th Feb 20212:05 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20219:05 amRNSSecond Price Monitoring Extn
26th Feb 20219:00 amRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSFirst Day of Dealings
16th Mar 201210:04 amPRNPossible Cancellation of AIM Listing
12th Mar 201212:16 pmPRNAGM Statement and Directorate Changes
6th Feb 20127:00 amPRNFinal Results
3rd Oct 20117:00 amPRNPlacing and Issue of Equity
28th Sep 20113:00 pmRNSSuspension - Cubus Lux Plc
28th Sep 20113:00 pmPRNSuspension pending publication of annual accounts
14th Jul 20115:42 pmPRNPlacing and Issue of Equity
13th Jul 20117:00 amPRNPlacing and Issue of Equity - Corrective Announcement
12th Jul 20119:07 amPRNPlacing and Issue of Equity
3rd Jun 20117:00 amPRNChange of Broker
4th May 20118:43 amPRNPlacing and Issue of Equity
5th Apr 20117:00 amPRNIssue of equity and Trading update
15th Feb 20117:00 amPRNIssue of Equity
23rd Dec 20108:15 amPRNIssue of Equity
22nd Dec 20107:00 amPRNHalf-yearly Report
3rd Nov 201010:54 amPRNCorrection : Nominated Adviser - Change of Name
3rd Nov 20107:00 amPRNNominated Adviser and Broker - Change of Name
28th Oct 201011:10 amPRNResult of AGM
28th Oct 201010:00 amPRNAGM Statement
27th Sep 20104:15 pmRNSFinal Results
31st Aug 20107:00 amPRNIssue of Equity
14th Jul 20107:00 amPRNIssue of Equity
2nd Jul 20107:00 amRNSGrant of Options
7th May 20107:00 amRNSRe-pricing of Options
23rd Feb 20104:23 pmPRNDirector's Dealing
31st Dec 20097:00 amRNSExtension of Casino Licences and Issue of Equity
22nd Dec 20097:00 amPRNHalf-yearly Report
21st Dec 20099:16 amPRNChange of Adviser
3rd Nov 20091:04 pmPRNResult of AGM
9th Oct 200910:16 amPRNNotice of AGM
30th Sep 20097:00 amPRNFinal Results
30th Jun 20099:51 amPRNIssue of Equity
11th May 200912:42 pmPRNTrading Statement
29th Apr 20097:00 amPRNTender win - Valdanos, Montenegro
2nd Apr 200910:23 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.